Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
55,482,166
-
Number of holders
-
108
-
Total 13F shares, excl. options
-
29,835,329
-
Shares change
-
-426,012
-
Total reported value, excl. options
-
$376,668,426
-
Value change
-
-$3,115,117
-
Number of buys
-
48
-
Number of sells
-
-57
-
Price
-
$12.62
Significant Holders of Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) as of Q2 2020
129 filings reported holding VYGR - Voyager Therapeutics, Inc. - Common Stock, $0.001 par value as of Q2 2020.
Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) has 108 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29,835,329 shares
of 55,482,166 outstanding shares and own 54% of the company stock.
Largest 10 shareholders include TRV GP III, LLC (6,391,176 shares), Bellevue Group AG (2,712,083 shares), BlackRock Inc. (2,628,767 shares), VANGUARD GROUP INC (2,271,288 shares), ARMISTICE CAPITAL, LLC (2,078,000 shares), Clearbridge Investments, LLC (1,378,311 shares), STATE STREET CORP (1,281,866 shares), Bank of New York Mellon Corp (1,122,435 shares), RENAISSANCE TECHNOLOGIES LLC (845,680 shares), and Casdin Capital, LLC (750,000 shares).
This table shows the top 108 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.